CBD is a CB1 antagonist which has a weak affinity to the CB1 receptor, meaning it doesn’t bind pretty strongly. From the pharmacological perspective, it’s very similar to THC, plus the really minimal study that has been accomplished on it implies it's related consequences, just with reduced potency. This is https://thcdisposables.co.uk/